Treating Thrombosis in the 21st Century

New England Journal of Medicine

Volumn 349, Issue 18, 2003, Pages 1762-1764

  Shapiro, Sandor S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; XIMELAGATRAN;

BLEEDING; DEEP VEIN THROMBOSIS; EDITORIAL; HISTORY OF MEDICINE; HUMAN; LUNG EMBOLISM; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOSIS;

ANTICOAGULANTS; AZETIDINES; BENZYLAMINES; FACTOR XA; FIBRINOLYTIC AGENTS; HEPARIN; HISTORY, 20TH CENTURY; HUMANS; POLYSACCHARIDES; PRODRUGS; THROMBOSIS; WARFARIN;

EID: 0142182554     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe038152     Document Type: Editorial

References (9)

1. Hirsh J, Anand SS, Halperin JL, Fuster V. Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. Circulation 2001;103:2994-3018.
2. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 2003;107:1692-711.
3. The Matisse Investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003;349:1695-702.
4. Francis CW, Berkowitz SD, Comp PC, et al. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med 2003;349: 1703-12.
5. Schulman S, Wählander K, Lundström T, Clason SB, Eriksson H. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. N Engl J Med 2003;349: 1713-21.
6. Findik S, Erkan ML, Selcuk MB, Albayrak S, Atici AG, Doru F. Low-molecular-weight heparin versus unfractionated heparin in the treatment of patients with acute pulmonary thromboembolism. Respiration 2002;69:440-4.
7. Patterson C, Stouffer GA, Madamanchi N, Runge MS. New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology. Circ Res 2001;88:987-97.
8. Coughlin SR. PARticipation in inflammation. J Clin Invest 2003; 111:25-7.
9. Moons AH, Peters RJ, Bijsterveld NR, et al. Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty. J Am Coll Cardiol 2003;41:2147-53.